CNGA3 and achromatopsia: Mouse models of CNGA3 and CNGB3 achromatopsia showed cone dysfunction and have been used to evaluate the efficacy of gene augmentation therapy (Biel et al., 1999; Carvalho et al., 2011; Pang et al., 2012).